Cardinal Health Inc. has agreed to sell its Chinese pharmaceutical and medical-products distribution business to a local rival, in the latest pullback by a U.S. company in the world’s second-largest economy.
Trending:
Cardinal Health pulls back from China with $557M sale to Hong Kong firm